Koers Hua Medicine (Shanghai) Ltd. OTC Markets
Aandelen
HUMDF
KYG4644K1022
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,2028 USD | -54,93% | -.--% | -.--% |
Omzet 2022 | 17,6 mln. 2,43 mln. 2,24 mln. | Omzet 2023 | 76,61 mln. 10,58 mln. 9,75 mln. | Marktkapitalisatie | 1,75 mld. 242 mln. 223 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -204 mln. -28,17 mln. -25,97 mln. | Nettowinst (verlies) 2023 | -211 mln. -29,14 mln. -26,86 mln. | EV/omzet 2022 | 159 x |
Nettoliquiditeiten 2022 | 393 mln. 54,27 mln. 50,03 mln. | Nettoliquiditeiten 2023 | 1,29 mld. 179 mln. 165 mln. | EV/omzet 2023 | 6 x |
K/w-verhouding 2022 |
-15,7
x | K/w-verhouding 2023 |
-8,28
x | Werknemers | 177 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 86,36% |
Recentste transcriptie over Hua Medicine (Shanghai) Ltd.
1 dag | -54,93% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Li Chen
FOU | Founder | 61 | 10-11-09 |
Li Changhong
CTO | Chief Tech/Sci/R&D Officer | 55 | - |
Di Hong
COO | Chief Operating Officer | 45 | 01-05-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Nelsen
CHM | Chairman | 60 | 23-04-10 |
William Keller
BRD | Director/Board Member | 75 | - |
Yiu Wa Tsui
BRD | Director/Board Member | 74 | 01-09-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+12,30% | 116 mld. | |
+12,15% | 106 mld. | |
-8,14% | 23,89 mld. | |
-1,69% | 21,58 mld. | |
-10,60% | 18,96 mld. | |
-41,25% | 16,96 mld. | |
-15,33% | 16,33 mld. | |
+5,80% | 14,14 mld. | |
+28,03% | 12,02 mld. |
- Beurs
- Aandelen
- Koers 2552
- Koers HUMDF